A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts
Cited by 217
Related Papers
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU
|American Journal of Respiratory and Critical Care Medicine|2018|126
Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohort
|Journal of Intensive Care|2019|45
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation
|Journal of Clinical Medicine|2024|31